花旗发表研究报告指出，中国人寿(02628.HK) 开启正面催化剂观察，原因是预期其将交出全面的2025财年业绩，并录得强劲的2026年第一季新业务价值增长。该行预期国寿2025财年净利润增长达47%，对比同业增长介乎6%至43%，跑赢大部分同业。新业务价值增长方面，该行预期国寿按可比口径计算将录得38%的按年增长，同样超越大部分同业。此外，花旗预期国寿管理层将于2025财年业绩发布会上就今年...
Source Link花旗发表研究报告指出，中国人寿(02628.HK) 开启正面催化剂观察，原因是预期其将交出全面的2025财年业绩，并录得强劲的2026年第一季新业务价值增长。该行预期国寿2025财年净利润增长达47%，对比同业增长介乎6%至43%，跑赢大部分同业。新业务价值增长方面，该行预期国寿按可比口径计算将录得38%的按年增长，同样超越大部分同业。此外，花旗预期国寿管理层将于2025财年业绩发布会上就今年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.